Using mouse models, it has been shown that breast, lung, and prostate cancer cells overexpressing CXCR4 and CXCR7 increased their ability to extravasate and colonize bone (15, 16), and CXCR4 inhibition decreased bone and lung metastases (17, 18). This evidence concerns the gene CXCR4 and prostate carcinoma.